Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Effects of Ketamine and Risperidone on Cognition (Schiz_2)

This study has been completed.
Sponsor:
Collaborators:
Cardiff University
King's College London
P1vital Limited
Information provided by (Responsible Party):
Bill Deakin, University of Manchester
ClinicalTrials.gov Identifier:
NCT01140620
First received: June 8, 2010
Last updated: November 7, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2010
  Primary Completion Date: November 2010 (Final data collection date for primary outcome measure)